Sectorale waarderingen Hyloris Pharmaceuticals SA
Aandelen
HYL
BE0974363955
Farmaceutische producten
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 6,000 EUR | 0,00% |
|
-1,32% | -8,26% |
| 23/11 | Farmazwaargewichten helpen Bel20 schade beperken | AM |
| 19/11 | Hyloris Pharmaceuticals benoemt co-CEO tot enige Chief Executive Officer | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | k/w-verhouding (Y) | Koers-boekwaarde (Y) | PEG (Y) | EV/omzet (Y) | Beurskap. / EBITDA (Y) | Beurskap. / EBIT (Y) | Dividendrendement (Y) | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | -14.29x | - | -0.17x | 17.27x | -12.01x | -11.38x | - | 196 mln. | |
| 42.94x | 32.34x | 0.45x | 14.23x | 31.57x | 33.91x | 0,6% | 879 mld. | |
| 19.08x | 6.13x | 0.24x | 5.36x | 14.83x | 16.27x | 2,58% | 482 mld. | |
| 52.09x | -538.36x | 0.66x | 7.39x | 17.5x | 18x | 2,93% | 394 mld. | |
| 18.3x | 6.53x | 0.27x | 4.6x | 11.51x | 13.06x | 3,13% | 335 mld. | |
| 27.25x | 6.15x | 0.57x | 5.16x | 15.31x | 16.11x | 1,78% | 281 mld. | |
| 18.3x | 5.73x | 0.82x | 4.95x | 11.64x | 12.54x | 3,08% | 254 mld. | |
| 12.52x | 4.47x | 0.84x | 4.1x | 8.77x | 9.9x | 3,34% | 240 mld. | |
| 12.97x | 7.05x | 6.8x | 4.66x | 9.65x | 11.15x | 3,89% | 207 mld. | |
| 23.98x | 18.96x | 0.33x | 5.88x | 10.1x | 13.5x | 3,04% | 169 mld. | |
| 17.41x | 6.53x | 0.01x | 5.51x | 10.07x | 12.1x | 2,77% | 148 mld. | |
| 13.11x | 1.59x | 0.35x | 2.95x | 7.43x | 8.56x | 6,73% | 144 mld. | |
| 12.11x | 1.29x | 0.24x | 2.62x | 8.5x | 9.44x | 4,99% | 118 mld. | |
| 28.14x | 5.94x | -0.03x | 8.49x | 18.34x | 19.05x | -.--% | 111 mld. | |
| 11.97x | 5.21x | -0.06x | 2.84x | 8.26x | 8.61x | 4,88% | 103 mld. | |
| 12.74x | 4.99x | 0.1x | 2.64x | 7.79x | 8.93x | 3,65% | 95,31 mld. | |
| 31.44x | 6.84x | 2.96x | 10.13x | 19.82x | 21.2x | 3,1% | 85,87 mld. | |
| 47.56x | 6.95x | 1.46x | 11.51x | 37.8x | 39.75x | 0,44% | 59,32 mld. | |
| 181.64x | 65.59x | -0.89x | 14.22x | 93.91x | 90.91x | -.--% | 54,85 mld. | |
| Gemiddelde | 29,96x | -19,23x | 0,79x | 7,08x | 17,41x | 18,51x | 2,83% | 219 mld. | |
| Gewogen gemiddelde per kap. | 29,46x | -38,95x | 0,79x | 7,35x | 18,03x | 19,46x | 2,52% |
- Beurs
- Aandelen
- Koers HYL
- Sector Hyloris Pharmaceuticals SA
- Sectorale waarderingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
